About us

Investing in companies addressing high unmetmedical needs

We are a major European venture capital firm. Our international team is driven by science, with the ambition to transform capital into medical breakthroughs.

We foster a positive impact on patients and society by funding the development of transformative treatments

Our philosophy

At Ysios Capital, the management team and strength
of science of each venture are key to our investment thesis.

We invest in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need.

Our impact



medical products brought from
lab to market


medical products at clinical
stage for serious diseases


collaborations with leading
research institutions


invested in
therapeutic R&D

Our focus

We invest globally in biotech ventures, focusing exclusively on innovative therapeutic drugs.

We seek exceptional teams with pioneering science and the drive to change patients' lives.

Our footprint

Ysios Capital was founded in 2008 and has offices in San Sebastian and Barcelona. With more than €400M AUM, we are the largest life sciences venture capital firm in Spain, with our investment successes providing a significant boost to the country’s biotech sector.

Since our inception, we have grown rapidly to become a leading global investment firm.

Our commitment

Ysios Capital is committed to responsible investment. We strive to integrate ESG principles and best practices across all our activities, as well as those of our portfolio companies and investors.

Our funds provide venture capital to carefully selected private biotech companies developing novel therapeutics to address areas of critical unmet need

We manage over €400M ($500M ) in assets
across three global funds

Ysios BioFund III


Investing in asset-centric companies and product-enabling platform technologies with proprietary products.

Fund size:€216 million
Target:Up to 15 companies

Current Portfolio